Abstract
Multiple sclerosis is generally regarded to be a primarily T-cell driven disease. Recent evidence has refocused interest on antibodies. Adhesion molecules, matrix metalloproteinases, chemokines and cytokines, and nitric oxide and oxygen metabolites all participate in the amplification and effector stages of the disease.
Original language | English |
---|---|
Pages (from-to) | 323-336 |
Number of pages | 14 |
Journal | Current Opinion in Neurology |
Volume | 12 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1999 |
ASJC Scopus subject areas
- Neuroscience(all)